Aemetis, Inc. (AMTX) Stock Forecast

NASDAQ: AMTXAnalyst ratings, price target and estimates.

AMTX analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.50 / 5 from 4 analysts
Price target
$13.38
average of analyst targets
Upside to target
+816.1%
from the latest close
Next earnings
November 5, 2026
EPS estimate $-0.20
52-week range
$1.32 – $3.66

AMTX analyst ratings

4 analysts
Strong buy
375%
Buy
00%
Hold
125%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

AMTX price target

Price $1.46Target $13.38
52-week low $1.3252-week high $3.66

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

AMTX earnings per share estimates

Aemetis, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.18−$0.18−$0.18−$0.37+51.7%1
Current fiscal year (2026)−$0.85−$0.85−$0.85−$1.30+34.4%1
Next fiscal year (2027)−$0.51−$0.52−$0.50−$0.85+40.1%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

AMTX revenue estimates

Aemetis, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$71.2M$67.2M$75.8M+20.4%4
Current fiscal year (2026)$259.7M$240.1M$272.6M+31.4%4
Next fiscal year (2027)$374.2M$368.4M$380.7M+44.1%4

AMTX EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

AMTX revenue: reported and forecast

Reported revenueEstimate (average; low–high)

AMTX EPS estimate revisions

Aemetis, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.19−$0.19−$0.19−$0.19−$0.18−3.1%1 up · 0 down
Current fiscal year (2026)−$0.91−$0.90−$0.90−$0.88−$0.85−6.1%1 up · 0 down
Next fiscal year (2027)−$0.59−$0.59−$0.59−$0.49−$0.51−13.6%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

AMTX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; AMTX beat in 5 of 12.

What analysts expect from AMTX

4 analysts cover Aemetis; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $13.38, 816.1% above the latest close of $1.46. Analysts expect earnings of −$0.85 per share for 2026, +34.4% from a year earlier. For 2027 the average estimate is −$0.51 per share on revenue of $374.2 million. Aemetis beat the EPS estimate in 5 of the last 12 quarters.

Related: AMTX income statement, AMTX key metrics, AMTX chart. See the AMTX stock overview for the latest quote and news.

AMTX forecast FAQ

What is Aemetis's price target?

The average analyst price target for Aemetis is $13.38, 816.1% above the latest close of $1.46.

Is Aemetis a buy, hold or sell?

Of 4 analysts covering Aemetis, 3 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Aemetis's EPS forecast?

Analysts forecast −$0.85 per share for 2026 (range −$0.85 to −$0.85); for 2027 the estimate is −$0.51.

What is Aemetis's revenue forecast?

The average revenue estimate for 2026 is $259.7 million, growth of 31.4%; for 2027 it is $374.2 million.

When does Aemetis report earnings?

Aemetis is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $-0.20.

Does Aemetis usually beat earnings estimates?

Aemetis reported EPS at or above the analyst estimate in 5 of the last 12 quarters.

Specialty Chemicals: forecast